131I-MIBG Therapy Combined With High-Dose Chemotherapy as First-Line Treatment Improves Clinical Outcomes in Newly Diagnosed High-Risk Neuroblastoma: Single Institutional Experience

被引：0
|
作者：
Kuroda, Rie [1 ]
Araki, Raita [1 ,4 ]
Noguchi, Kazuhiro [1 ]
Fujiki, Toshihiro [1 ]
Ikawa, Yasuhiro [1 ]
Mase, Shintaro [1 ]
Fukuda, Masaki [1 ]
Wakabayashi, Hiroshi [2 ]
Inaki, Anri [2 ]
Kayano, Daiki [2 ]
Sakai, Seisyo [3 ]
Maeba, Hideaki [1 ]
Nishimura, Ryosei [1 ]
Kinuya, Seigo [2 ]
Wada, Taizo [1 ]
机构：
[1] Kanazawa Univ, Dept Pediat, Kanazawa, Ishikawa, Japan
[2] Kanazawa Univ, Dept Nucl Med Biotracer Med, Kanazawa, Ishikawa, Japan
[3] Kanazawa Univ, Dept Pediat Surg, Kanazawa, Ishikawa, Japan
[4] Ishikawa Prefectural Cent Hosp, Dept Pediat, Kanazawa, Ishikawa, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2019年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS43-3-5
引用
收藏
页码：S108 / S108
页数：1
相关论文
共 50 条
  • [21] Timing and chemotherapy association for 131-I-MIBG treatment in high-risk neuroblastoma
    Mastrangelo, Stefano
    Romano, Alberto
    Attina, Giorgio
    Maurizi, Palma
    Ruggiero, Antonio
    BIOCHEMICAL PHARMACOLOGY, 2023, 216
  • [22] Dosimetry-based high-activity therapy with 131I-metaiodobenzylguanidine (131I-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma
    Jose Genolla
    Trinidad Rodriguez
    Pablo Minguez
    Ricardo Lopez-Almaraz
    Veronica Llorens
    Aizpea Echebarria
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1567 - 1575
  • [23] Tandem high-dose 131I-MIBG therapy supported by dosimetry in pediatric patients with relapsed-refractory high-risk neuroblastoma: the Bambino Gesu' Children's Hospital experience
    Altini, Claudio
    Villani, Maria F.
    Di Giannatale, Angela
    Cassano, Bartolomeo
    Pizzoferro, Milena
    Serra, Annalisa
    Castellano, Aurora
    Cannata, Vittorio
    Garganese, Maria C.
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (02) : 129 - 144
  • [24] Dosimetry-based high-activity therapy with 131I-metaiodobenzylguanidine (131I-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma
    Genolla, Jose
    Rodriguez, Trinidad
    Minguez, Pablo
    Lopez-Almaraz, Ricardo
    Llorens, Veronica
    Echebarria, Aizpea
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (07) : 1567 - 1575
  • [25] Treatment planning for 131I-mIBG Radionuclide therapy of high-risk neuroblastoma based on patient-specific Dosimetry
    Buckley, S.
    Saran, F.
    Gaze, M.
    Hindorf, C.
    Chittenden, S.
    Lancaster, D.
    Pearson, A.
    Flux, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S179 - S179
  • [26] Upfront consolidation treatment with 131I-mIbG followed by myeloablative chemotherapy and hematopoietic stem cell transplantation in high-risk neuroblastoma
    Feng, Jianhua
    Cheng, Frankie W. T.
    Leung, Alex W. K.
    Lee, Vincent
    Yeung, Eva W. M.
    Lam, Hoi Ching
    Cheung, Jeanny
    Lam, Grace K. S.
    Chow, Terry T. W.
    Yan, Carol L. S.
    Li, Chi Kong
    PEDIATRIC INVESTIGATION, 2020, 4 (03) : 168 - 177
  • [27] Reaching the target dose with one single 131I-mIBG administration in high-risk neuroblastoma: The determinant impact of the primary tumour
    Fiz, Francesco
    Cirone, Alessio
    Righi, Sergio
    Massollo, Michela
    Amoroso, Loredana
    Bottoni, Gianluca
    Conte, Massimo
    Gambaro, Monica
    Massone, Federico
    Orengo, Stefano
    Bruzzone, Guido Semino
    Sorrentino, Stefania
    Garaventa, Alberto
    Piccardo, Arnoldo
    PEDIATRIC BLOOD & CANCER, 2024, 71 (03)
  • [28] I-131-mIBG therapy in high-risk neuroblastoma patients at end of induction chemotherapy
    Schmidt, M. C.
    Hero, B.
    Decarolis, B.
    Eggert, A.
    Berthold, F.
    Drzezga, A.
    Simon, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S772 - S772
  • [29] Radiation exposure in nurses during care of 131I-MIBG therapy for pediatric patients with high-risk neuroblastoma
    Yuka Taniguchi
    Hiroshi Wakabayashi
    Anri Inaki
    Daiki Kayano
    Masako Yamada
    Seigo Kinuya
    Annals of Nuclear Medicine, 2020, 34 : 441 - 447
  • [30] High-dose chemotherapy with transplant yields encouraging outcomes as first-line treatment for patients with high-risk aggressive lymphoma
    不详
    CLINICAL LYMPHOMA, 2003, 3 (04): : 205 - 206
12345